LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Actinium Pharmaceuticals Inc

Chiusa

1.81 8.38

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.62

Massimo

1.84

Metriche Chiave

By Trading Economics

Entrata

-9.3M

-16M

EPS

-0.51

Dipendenti

31

EBITDA

-9.3M

-17M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+255.03% upside

Dividendi

By Dow Jones

Utili prossimi

1 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

2.2M

51M

Apertura precedente

-6.57

Chiusura precedente

1.81

Actinium Pharmaceuticals Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 giu 2025, 20:45 UTC

Utili

Broadcom 2Q Sales Climb on Booming AI Demand

5 giu 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 giu 2025, 23:44 UTC

Discorsi di Mercato

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 giu 2025, 23:30 UTC

Discorsi di Mercato

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 giu 2025, 21:32 UTC

Utili

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 giu 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

5 giu 2025, 20:45 UTC

Utili

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 giu 2025, 20:24 UTC

Utili

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q Rev $15B >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q Net $4.97B >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q Adj EPS $1.58 >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q EPS $1.03 >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom Sees 3Q Rev $15.8B >AVGO

5 giu 2025, 20:11 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 giu 2025, 20:11 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 giu 2025, 20:11 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 giu 2025, 19:22 UTC

Discorsi di Mercato

Oil Futures Resume Upward Moves -- Market Talk

5 giu 2025, 19:00 UTC

Discorsi di Mercato

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 giu 2025, 18:32 UTC

Discorsi di Mercato

Gold Slips After Trump-Xi Call -- Market Talk

5 giu 2025, 18:26 UTC

Utili

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 giu 2025, 18:06 UTC

Discorsi di Mercato

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 giu 2025, 16:30 UTC

Acquisizioni, Fusioni, Takeovers

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 giu 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

5 giu 2025, 16:18 UTC

Discorsi di Mercato

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 giu 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

5 giu 2025, 16:12 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

5 giu 2025, 16:12 UTC

Discorsi di Mercato

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 giu 2025, 16:03 UTC

Discorsi di Mercato

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 giu 2025, 15:49 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Actinium Pharmaceuticals Inc Previsione

Obiettivo di Prezzo

By TipRanks

255.03% in crescita

Previsioni per 12 mesi

Media 6 USD  255.03%

Alto 9 USD

Basso 4 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Actinium Pharmaceuticals Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

3

Acquista

0

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.